Company / SG&A Expense
Global Medical REIT Inc. SG&A Expense History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$21.1M
FY2024
5-year range
$11.9M / $21.1M
FY2020-FY2024
Trend
+25.3%
vs FY2023
Sector context
#121 of 130
Real Estate
What the data says
Among 130 Real Estate companies, Global Medical REIT Inc. is in the top 7% for sg&a expense. SG&A Expense has increased for 9 consecutive years, from $425,000 in FY2015 to $21M in FY2024.
Based on SEC 10-K filings.
$21M in FY2024 with a 5-year CAGR of +26.4%.
Increased from $17M to $21M over the past 2 years.
Real Estate sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +8.7%
- 5-Year CAGR
- +26.4%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Real EstateTop 7% of 130This company $21.1M Sector average $159.9M
▼
-86.8% below sector average
Key checks
Key Insights
- Global Medical REIT Inc.'s sg&a expense has grown for 9 consecutive years.
- 5-year CAGR of +26.4%, indicating consistent growth.
- In FY2024, sg&a expense increased 25.3% year-over-year.
- Ranks #121 out of 130 companies in the Real Estate sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $21.1M | +25.3% |
| FY2023 | $16.9M | +1.9% |
| FY2022 | $16.5M | +0.6% |
| FY2021 | $16.5M | +37.9% |
| FY2020 | $11.9M | +82.6% |
| FY2019 | $6.5M | +18.0% |
| FY2018 | $5.5M | +0.9% |
| FY2017 | $5.5M | +30.1% |
| FY2016 | $4.2M | +892.7% |
| FY2015 | $425.0K | +132.3% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026